This inventor holds 1 USPTO granted patent. Top assignee: Coulter Pharmaceutical, Inc.. Active years: 1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1999
Title: Albert S. Chan: Innovator in Radioprotectant Technologies
Introduction
Albert S. Chan is a notable inventor based in Ottawa, Canada. He has made significant contributions to the field of radioprotectants, particularly in the development of methods to enhance the stability of radiolabeled peptides. His innovative work has implications for various applications, especially in the medical and pharmaceutical industries.
Latest Patents
Albert S. Chan holds a patent for a radioprotectant for peptides labeled with radioisotope. This patent describes a method of ameliorating the degradation of radiolabeled peptides, particularly radiolabeled proteins such as antibodies. The invention includes the use of povidone, also known as polyvinylpyrrolidone or PVP, as a radioprotectant in a composition containing a radiolabeled peptide. Additionally, the patent outlines a radioprotectant composition and a stable peptide-radioisotope composition that incorporates povidone. The inclusion of ascorbic acid or other secondary stabilizers may further enhance the radioprotection offered by these compositions.
Career Highlights
Albert S. Chan is associated with Coulter Pharmaceutical, Inc., where he applies his expertise in radioprotectant technologies. His work at the company has allowed him to focus on innovative solutions that address challenges in the field of radiolabeled peptides. His contributions have been instrumental in advancing the understanding and application of radioprotectants in pharmaceuticals.
Collaborations
Throughout his career, Albert has collaborated with notable colleagues, including David Colcher and Dan Shochat. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.
Conclusion
Albert S. Chan is a distinguished inventor whose work in radioprotectant technologies has made a significant impact in the field. His patent for a radioprotectant for peptides labeled with radioisotope showcases his innovative approach to solving complex problems in the pharmaceutical industry. His contributions continue to influence advancements in medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile